We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MCI Medcaw Investments Plc

0.00 (0.0%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medcaw Investments Plc LSE:MCI London Ordinary Share GB00BM8SQP62 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 4.25 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices-holdng Companies,nec -194k -0.0113 -3.76 728.11k
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 4.25 GBX

Medcaw Investments (MCI) Latest News

Medcaw Investments (MCI) Discussions and Chat

Medcaw Investments Forums and Chat

Date Time Title Posts
18/7/202316:37Medcaw Investments: Lithium Mining Shell (Ex Life Sciences Shell)-
04/4/201120:42McInerney with Charts & News109
21/5/200709:11Director deals10
04/8/200608:19Mcinnery Holdings30

Add a New Thread

Medcaw Investments (MCI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Medcaw Investments (MCI) Top Chat Posts

Top Posts
Posted at 04/12/2023 08:20 by Medcaw Investments Daily Update
Medcaw Investments Plc is listed in the Offices-holdng Companies,nec sector of the London Stock Exchange with ticker MCI. The last closing price for Medcaw Investments was 4.25p.
Medcaw Investments currently has 17,132,090 shares in issue. The market capitalisation of Medcaw Investments is £728,114.
Medcaw Investments has a price to earnings ratio (PE ratio) of -3.76.
This morning MCI shares opened at -
Posted at 18/7/2023 16:37 by hedgehog 100
Current share price 18th. July 2023: 4.25p (currently suspended)
22,132,095 shares in issue
Market capitalisation: £940,614.

"On incorporation, the Company issued 5,000,000 Ordinary Shares at an issue price of £0.01 each to raise £50,000.
On 10 February 2021, the Company issued a further 4,750,000 Ordinary Shares at a subscription price of £0.04 as part of the Seed Fundraise, raising a total of £190,000."

MCI raised £0.45M. net in its December 2022 float, at 10p/share.
And on 7th. July 2023 raised a further £400K. gross at 8p/share.

21/12/2022 08:00 UK Regulatory (RNS & others) Medcaw Investments Plc First Day of Dealings on the London Stock Exchange LSE:MCI Medcaw Investments Plc

"Medcaw Investments plc, a company formed for the purpose of undertaking an
acquisition or acquisitions in the life sciences sector life sciences sector,
focusing on companies developing medical or wellness technologies and
therapies, is pleased to announce that, following the publication of its
Prospectus on 16 December 2022, a total of 17,132,095 ordinary shares of £0.01
each in the share capital of the Company will today be admitted to the standard
segment of the Official List of the Financial Conduct Authority and to trading
on the main market for listed securities of the London Stock Exchange plc.

Dealings will commence at 8:00 a.m. today under the TIDM 'MCI' with ISIN number

07/07/2023 16:12 PR Newswire (US) Medcaw Investments Plc - Potential acquisition of near-term Lithium production asset LSE:MCI Medcaw Investments Plc

"Potential acquisition of near-term Lithium production asset

• Signing of conditional implementation agreement with Abyssinian Metals Limited
• Equity Fundraise & Suspension of Trading

Medcaw Investments plc (LSE:MCI), an acquisition vehicle, is pleased to announce that it has entered into a conditional implementation agreement with Abyssinian Metals Limited ("AML"), a company incorporated in Australia and developing the Kenticha lithium project located in Oromia State, Southern Ethiopia.

Subject to the Company being satisfied with technical, legal, accounting, tax, financial, commercial and environmental due diligence on AML the Company will consider making an offer to acquire up to 100% of the entire issued share capital of AML ("AML Shares") in consideration for the issue and allotment of new ordinary shares ("Ordinary Shares") in the Company to the shareholders of AML ("Proposed Transaction"). As at the date of this announcement no decision has made by the Company whether to proceed with an offer for the AML Shares or otherwise and there is no offer that is capable of being accepted by the shareholders of AML.

AML is a clean energy metals company with a focus on the development of the Kenticha lithium project in which it has a 51% legal and beneficial interest and manager of the project with the Oromia State holding 49%. ...

Details of Equity Fundraise

Medcaw has today raised gross proceeds of £400,000 at 8p per share ("New Ordinary Shares") through an equity placement to various high net worth and institutional investors introduced by GIS Global Investment Strategy ("GIS") ("Placement"). The Company has therefore allotted and issued a total of 5,000,000 new Ordinary Shares in the Company. ..."

From MCI's website:-

"About us

Medcaw Investments PLC (“Medcaw”) is a cash shell listed on the Main Market of the London Stock Exchange MCI:LON. Medcaw has recently entered into binding conditional agreement to acquire Abyssinian Metals Limited ("AML"), a company developing the Kenticha lithium project located in Oromia State, Southern Ethiopia. The Kenticha project is a highly evolved, rare element, Lithium Caesium Tantalum (LCT) pegmatite project comparable to other major rare-element pegmatites such as Greenbushes, Tanco, Wodgina, Volta Grande and Altai No.3. Kenticha is a late stage development asset which AML intends to develop with the production of spodumene concentrate planned in stages, with near-term production through a Dense Medium Separation (DMS) modular plant.

At Medcaw we recognise the significant role that lithium plays in the global transition to sustainable energy solutions. As the demand for clean energy continues to surge, lithium has become an indispensable element in the production of lithium-ion batteries, which power electric vehicles and store renewable energy.

Our primary objective is to identify and acquire prospective lithium mining projects across Africa, a continent rich in mineral resources and untapped potential. We believe that Africa presents a unique opportunity for lithium mining, with its abundant lithium deposits and favorable investment climate. By focusing on this region, we aim to become a key player in the lithium market, meeting the growing demand and contributing to the sustainable energy revolution."
Posted at 13/8/2010 07:08 by andrbea
mci was ca 7.5p in June
With news of new cash injector (Aug 9) looks like it's trying to edge back up;
up 12% today

no volume though and an ugly spread.
Posted at 16/4/2010 20:58 by lbo
Quinn must be perplexed at the goings-on over at McInerney

Sean Quinn says he bitterly regrets his investment in Anglo Irish Bank, but the Cavan man must be stunned by what's happening over at McInerney, the housebuilder, where his insurance company has a stake of almost 5pc.

The score card of the current management team is pretty dismal and now a key member of that management team, chief executive Barry O'Connor, is stepping aside in an attempt to buy up its Spanish operations. Shareholders are understandably pretty upset at O'Connor already, but they will be even more upset if the Spanish assets are sold without getting the maximum possible value from the transaction.

The company's balance sheet is currently insolvent to the tune of €92.5m and the company is in breach of its bank covenants. The tale of woe doesn't stop there.

Writedowns in 2009 alone came to a crippling €127m and the company only has a market value of €26.2m. The decision of the company's management team to buy land banks in the run-up to the housing bust was a catastrophic error, although the company comments this week, presumably not ironically, that at least having access to land won't be a problem "when the market returns to growth''.

A more cautious battening down the hatches approach in the pre-credit crunch period would have saved the company's shareholders, including Mr Quinn, an awful lot of pain. Now the talk is of money being raised from existing shareholders, diluting the stakes of those hapless shareholders who don't want to incinerate any more of their cash. This presumably includes Mr Quinn?

Despite the appalling performance, the remuneration of directors actually rose last year to €3m as an executive director was compensated for loss of employment to the tune of €843,208. The Spanish deal with Mr O'Connor could make sense if the price is right, but after everything that has happened, shareholders are right to be deeply sceptical and also deeply annoyed.
Posted at 04/3/2010 21:53 by lbo
House prices in Europe remain above long-term average; Further price declines likely in Spain, Ireland
Posted at 29/1/2009 21:51 by lbo
McInerney grim results reflect house-price cuts
Posted at 12/12/2008 13:44 by lbo
Rents declining faster than house prices

One of the most interesting nuggets of information contained in yesterday's CPI report was the trend in private rents (which is reported on a quarterly basis). Although it has been clear that rental growth has been on a downward trajectory for some time, the latest evidence suggests a marked acceleration in this trend. Rents declined by 9.7% yoy in November, with the quarterly decline coming in at -7.1%, a record fall. With house prices estimated to have fallen by "only" 4% over the same time period, this implies that the residential rental yield actually declined in Q4. We estimate that it now stands at 4.0%, relative to 4.2% in Q3. Data from reveal that theren has been a threefold increase in the number of rental properties on the market since January 2007. With few properties being sold, vendors have decided to put their properties on the rental market instead. With outward migration flows increasing also, these factors are putting clear downward pressure on rents. Of course, sharply lower interest rates will help in the housing market, but the labour market environment has deteriorated further recently. Most importantly though, as our analysis of the unsold housing stock reveals, there are clear oversupply issues in the Irish housing market to be resolved if we are to call a bottom in the price downturn overall.
Posted at 30/7/2008 10:21 by lbo
HOUSE builder McInerney suffered a 9.7% dip in its share price yesterday to close at 32c.
Posted at 02/7/2008 12:15 by lbo
Price of a new home set to tumble
Posted at 11/6/2008 12:22 by lbo
Merrill Lynch reviewed the UK Housebuilding sector this morning, downgrading all the major players.

Barratt Developments, Bellway, Berkeley, Galliford Try and Redrow were moved from 'neutral' to 'underperform', while Persimmon was dropped to 'neutral' from 'buy'.

The broker has new price targets for Barratt at 90p, Bellway at 525p, Berkeley at 700p, Bovis at 300p, Galliford Try at 35p, Kier at 1,000p, Persimmon at 400p, Redrow at 170p and Taylor Wimpey at 70p.

In a note to clients, Merrill Lynch said it believes given the deteriorating market backdrop that UK housebuilders have experienced over the past three months, the early 1990s housing market recession has increasing relevance as a comparator.

The broker said it thinks unemployment levels will be of critical importance as the single most important determinant of consumer confidence and housing transactions as this was the case in the early 1990s recession.

If, as Merrill suspects, unemployment trends higher, then it thinks this will put additional pressure on housing transaction volumes and the broker advises, more than anything else, to watch this variable closely.

The broker has cut its volume and house price assumptions for 2009, with volume projections from flat to down 10% and house prices from 5% lower to a drop of 10%.

Merrill believes we have gone beyond the tipping point and are now clearly seeing a UK housing market being squeezed on opposing fronts, by a lack both of willing lenders, as well as willing purchasers.
Posted at 11/6/2008 11:52 by lbo
Housebuilder Barratt Developments saw its shares slump 29¼ to 91½p after brokers said there was no end in sight to the collapse in the housing market. In a savage note, Dresdner Kleinwort withdrew its target price on Barratt in a note titled: "Don't buy [at any price]," reports the Telegraph. Dresdner analyst Alastair Stewart said Barratt, which has debts of more than £1.7bn, would have to raise at least £1bn to survive. With a market capitalisation where it is, the company would have to embark on a rights issue of around five-for-one at a 50% discount, something it said was "possibly unfeasible"
Medcaw Investments share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |